LASTACAFT

Product NDC: 0023-4290
11-digit product format: 000234290
Labeler code: 0023
Product ID: 0023-4290_03500b7d-f60e-44a0-b57e-5030a35c82aa
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: alcaftadine
Dosage form: SOLUTION/ DROPS
Route: OPHTHALMIC
Labeler: Allergan, Inc.
Application: NDA022134
Marketing category: NDA
Marketing start: 2010-11-01
Substance: ALCAFTADINE
Active strength: 2.5 mg/mL
Pharmacologic classes: Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	0023-4290	0023-4290-03	D	Discontinued by firm		2026-08-10

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N022134-001	LASTACAFT	ALCAFTADINE	0.25%	SOLUTION/DROPS / OPHTHALMIC		RLD, RS	2010-07-28

Orange Book patents#

Current patent rows page 1 of 1 · 2 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12
N022134-001	8664215	2027-12-23	U-3267		2014-03-21

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`cb3db0bc1861…`

Observed Orange Book patent history#

Patent history page 1 of 2 · 78 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N022134-001	8664215	2027-12-23	U-1493		2014-03-21	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N022134-001	10617695	2027-03-19	U-1493	Drug product	2020-05-12	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N022134-001	8664215	2027-12-23	U-1493		2014-03-21	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N022134-001	10617695	2027-03-19	U-1493	Drug product	2020-05-12	`87673890dc5c…`

Additional Listing Data#

Finished product: Yes
Brand name base: LASTACAFT
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ALCAFTADINE	2.5 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
7Z8O94ECSX	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1000085	Internal RxNorm lookup
1000089	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
17d37e8d-7825-424b-b6ca-0a85d0bf4694	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
362d7abb-94e6-4c60-9a58-266894157713	Product name	1	20231023
6bd95106-a412-1dad-b9cc-4cb74bfb27ce	Product name	2	20230315
f1e0dc7e-7d61-4625-b6d9-4894927679d7	Product name	2	20211025
e4870509-7e28-6f92-f0be-dd3dd889a9cf	Product name	5	20200810
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cd	Product name	2	20190619
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
290f523a-f9db-9774-b5a9-e1f908ac1782	Product name	1	20150828
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
4b7a6bd5-956e-f134-86e5-d4d9706c15d4	Product name	1	20140508
5668b646-cd56-c3c7-bdea-3f6b1a8840db	Product name	1	20140508
684ea482-2e8b-14af-5664-b98f1e402036	Product name	1	20140508
810ab97e-f109-f41c-7c83-6a652a9cbf43	Product name	1	20140508
87711080-88eb-65c5-b2dd-bf99e700a372	Product name	1	20140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2dd	Product name	1	20140508
b060cc1a-fe47-856b-0b77-4448b5963de8	Product name	1	20140508
c6b65c52-69c7-df49-550a-a50c137f6218	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0023-4290-01	LASTACAFT	1 in 1 CARTON	SOLUTION/ DROPS	1	21
0023-4290-01	LASTACAFT	1 mL in 1 BOTTLE, PLASTIC	SOLUTION/ DROPS	1	21
0023-4290-03	LASTACAFT	1 in 1 CARTON	SOLUTION/ DROPS	1	21
0023-4290-03	LASTACAFT	3 mL in 1 BOTTLE, PLASTIC	SOLUTION/ DROPS	3	21

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0023-4290-03	ML - Milliliter	0023-4290	768cda39-1ce2-4415-83ce-8876eb65cc23	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
alcaftadine	ACTIVE INGREDIENT	7Z8O94ECSX	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [ALLERGAN, INC.]	8
alcaftadine	ACTIVE MOIETY	7Z8O94ECSX	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [ALLERGAN, INC.]	8
benzalkonium chloride	INACTIVE INGREDIENT	F5UM2KM3W7	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [ALLERGAN, INC.]	8
edetate disodium	INACTIVE INGREDIENT	7FLD91C86K	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [ALLERGAN, INC.]	8
hydrochloric acid	INACTIVE INGREDIENT	QTT17582CB	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [ALLERGAN, INC.]	8
sodium chloride	INACTIVE INGREDIENT	451W47IQ8X	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [ALLERGAN, INC.]	8
sodium hydroxide	INACTIVE INGREDIENT	55X04QC32I	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [ALLERGAN, INC.]	8
sodium phosphate, monobasic	INACTIVE INGREDIENT	3980JIH2SW	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [ALLERGAN, INC.]	8
water	INACTIVE INGREDIENT	059QF0KO0R	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [ALLERGAN, INC.]	8
alcaftadine	ACTIVE INGREDIENT	7Z8O94ECSX	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [REBEL DISTRIBUTORS CORP]	1
alcaftadine	ACTIVE INGREDIENT	7Z8O94ECSX	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [PHYSICIANS TOTAL CARE, INC.]	1
alcaftadine	ACTIVE MOIETY	7Z8O94ECSX	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [PHYSICIANS TOTAL CARE, INC.]	1
alcaftadine	ACTIVE MOIETY	7Z8O94ECSX	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [REBEL DISTRIBUTORS CORP]	1
benzalkonium chloride	INACTIVE INGREDIENT	F5UM2KM3W7	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [REBEL DISTRIBUTORS CORP]	1
benzalkonium chloride	INACTIVE INGREDIENT	F5UM2KM3W7	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [PHYSICIANS TOTAL CARE, INC.]	1
edetate disodium	INACTIVE INGREDIENT	7FLD91C86K	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [PHYSICIANS TOTAL CARE, INC.]	1
edetate disodium	INACTIVE INGREDIENT	7FLD91C86K	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [REBEL DISTRIBUTORS CORP]	1
hydrochloric acid	INACTIVE INGREDIENT	QTT17582CB	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [PHYSICIANS TOTAL CARE, INC.]	1
hydrochloric acid	INACTIVE INGREDIENT	QTT17582CB	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [REBEL DISTRIBUTORS CORP]	1
sodium chloride	INACTIVE INGREDIENT	451W47IQ8X	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [REBEL DISTRIBUTORS CORP]	1
sodium chloride	INACTIVE INGREDIENT	451W47IQ8X	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [PHYSICIANS TOTAL CARE, INC.]	1
sodium hydroxide	INACTIVE INGREDIENT	55X04QC32I	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [PHYSICIANS TOTAL CARE, INC.]	1
sodium hydroxide	INACTIVE INGREDIENT	55X04QC32I	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [REBEL DISTRIBUTORS CORP]	1
sodium phosphate, monobasic	INACTIVE INGREDIENT	3980JIH2SW	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [PHYSICIANS TOTAL CARE, INC.]	1
sodium phosphate, monobasic	INACTIVE INGREDIENT	3980JIH2SW	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [REBEL DISTRIBUTORS CORP]	1
water	INACTIVE INGREDIENT	059QF0KO0R	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [REBEL DISTRIBUTORS CORP]	1
water	INACTIVE INGREDIENT	059QF0KO0R	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [PHYSICIANS TOTAL CARE, INC.]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0023-4290	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [ALLERGAN, INC.]	20	Current NDC, Legacy NDC, 4 package rows	20241009_17d37e8d-7825-424b-b6ca-0a85d0bf4694.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
LASTACAFT	ALCAFTADINE	Allergan, Inc.	a3002410-4bf1-4182-9d7c-8193eb7cd215	2022-08-10	Warnings	Exact identifier application applno (NDA): 022134 application number: NDA022134
LASTACAFT	ALCAFTADINE	Allergan, Inc.	17d37e8d-7825-424b-b6ca-0a85d0bf4694	2020-06-01	Warnings, Adverse reactions	Exact identifier application applno (NDA): 022134 application number: NDA022134 ndc (product): 0023-4290

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
7Z8O94ECSX	ALCAFTADINE	147084-10-4	ALCAFTADINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1000085	alcaftadine 0.25 % Ophthalmic Solution	PSN	17d37e8d-7825-424b-b6ca-0a85d0bf4694	21
1000089	LASTACAFT 0.25 % Ophthalmic Solution	PSN	17d37e8d-7825-424b-b6ca-0a85d0bf4694	21
1000089	alcaftadine 2.5 MG/ML Ophthalmic Solution [Lastacaft]	SBD	17d37e8d-7825-424b-b6ca-0a85d0bf4694	21
1000085	alcaftadine 2.5 MG/ML Ophthalmic Solution	SCD	17d37e8d-7825-424b-b6ca-0a85d0bf4694	21
1000085	alcaftadine 0.25 % Ophthalmic Solution	SY	17d37e8d-7825-424b-b6ca-0a85d0bf4694	21
1000089	Lastacaft 0.25 % Ophthalmic Solution	SY	17d37e8d-7825-424b-b6ca-0a85d0bf4694	21
1000089	Lastacaft 2.5 MG/ML Ophthalmic Solution	SY	17d37e8d-7825-424b-b6ca-0a85d0bf4694	21
1000085	alcaftadine 0.25 % Ophthalmic Solution	PSN	c192fecc-046d-4905-868f-b8200320309c	1
1000085	alcaftadine 0.25 % Ophthalmic Solution	PSN	4b8c6afe-2d76-46c7-a23e-99db5e180ff6	1
1000089	LASTACAFT 0.25 % Ophthalmic Solution	PSN	4b8c6afe-2d76-46c7-a23e-99db5e180ff6	1
1000089	LASTACAFT 0.25 % Ophthalmic Solution	PSN	c192fecc-046d-4905-868f-b8200320309c	1
1000089	alcaftadine 2.5 MG/ML Ophthalmic Solution [Lastacaft]	SBD	4b8c6afe-2d76-46c7-a23e-99db5e180ff6	1
1000089	alcaftadine 2.5 MG/ML Ophthalmic Solution [Lastacaft]	SBD	c192fecc-046d-4905-868f-b8200320309c	1
1000085	alcaftadine 2.5 MG/ML Ophthalmic Solution	SCD	4b8c6afe-2d76-46c7-a23e-99db5e180ff6	1
1000085	alcaftadine 2.5 MG/ML Ophthalmic Solution	SCD	c192fecc-046d-4905-868f-b8200320309c	1
1000085	alcaftadine 0.25 % Ophthalmic Solution	SY	4b8c6afe-2d76-46c7-a23e-99db5e180ff6	1
1000085	alcaftadine 0.25 % Ophthalmic Solution	SY	c192fecc-046d-4905-868f-b8200320309c	1
1000089	Lastacaft 0.25 % Ophthalmic Solution	SY	4b8c6afe-2d76-46c7-a23e-99db5e180ff6	1
1000089	Lastacaft 0.25 % Ophthalmic Solution	SY	c192fecc-046d-4905-868f-b8200320309c	1
1000089	Lastacaft 2.5 MG/ML Ophthalmic Solution	SY	c192fecc-046d-4905-868f-b8200320309c	1
1000089	Lastacaft 2.5 MG/ML Ophthalmic Solution	SY	4b8c6afe-2d76-46c7-a23e-99db5e180ff6	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
0023-4290-01	00023429001	1 BOTTLE, PLASTIC in 1 CARTON (0023-4290-01) / 1 mL in 1 BOTTLE, PLASTIC	2010-11-01	0000-00-00	No	No	Current
0023-4290-03	00023429003	1 BOTTLE, PLASTIC in 1 CARTON (0023-4290-03) > 3 mL in 1 BOTTLE, PLASTIC	2010-11-01	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
LASTACAFT	Allergan, Inc.	2020-06-01	HUMAN PRESCRIPTION DRUG LABEL	21
LASTACAFT	Rebel Distributors Corp \| PSS World Medical, Inc. \| STAT RX USA LLC \| Dispensing Solutions, Inc. \| SCRIPT PAK \| Keltman Pharmaceuticals, Inc. \| Rebel Distirbutors Corp.	2012-09-05	HUMAN PRESCRIPTION DRUG LABEL	1
LASTACAFT	Physicians Total Care, Inc.	2010-09-30	HUMAN PRESCRIPTION DRUG LABEL	1